Nuclear Medicine and Biology

Journal

Publication Venue For

  • Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry.  118-119. 2023
  • 45Ti targeted tracers for PET imaging of PSMA.  108-109:16-23. 2022
  • A novel anti-angiogenic radio/photo sensitizer for prostate cancer imaging and therapy: 89Zr-Pt@TiO2-SPHINX, synthesis and in vitro evaluation.  94-95:20-31. 2021
  • Training the next generation of radiopharmaceutical scientists.  88-89:10-13. 2020
  • Improved production of 76Br, 77Br and 80mBr via CoSe cyclotron targets and vertical dry distillation.  80-81:32-36. 2020
  • Corrigendum to ‘212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models’ [Nucl Med Biol 58 (2018) 67–73] (S0969805117303396) (10.1016/j.nucmedbio.2017.12.004)).  61:71. 2018
  • 212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models.  58:67-73. 2018
  • Production of Zr-89 using sputtered yttrium coin targets 89Zr using sputtered yttrium coin targets.  50:11-16. 2017
  • B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models.  47:23-30. 2017
  • Imaging of hypoxia in mouse atherosclerotic plaques with 64Cu-ATSM.  43:534-542. 2016
  • Production and separation of 186gRe from proton bombardment of 186WC.  42:530-535. 2015
  • System a amino acid transport-targeted brain and systemic tumor PET imaging agents 2-amino-3-[(18)F]fluoro-2-methylpropanoic acid and 3-[(18)F]fluoro-2-methyl-2-(methylamino)propanoic acid..  42:8-18. 2015
  • Cyclotron Production of 99mTc using 100Mo2C targets.  40:939-945. 2013
  • Radiosynthesis and biological evaluation of alpha-[F-18]fluoromethyl phenylalanine for brain tumor imaging..  40:498-506. 2013
  • A historical perspective on the specific activity of radiopharmaceuticals: What have we learned in the 35years of the ISRC?.  40:314-320. 2013
  • Initial characterization of a dually radiolabeled peptide for simultaneous monitoring of protein targets and enzymatic activity.  40:190-196. 2013
  • A historical perspective on the specific activity of radiopharmaceuticals: What have we learned in the 35 years of the ISRC?.  39:601-608. 2012
  • Synthesis and biological evaluation of trans-3-phenyl-1-indanamines as potential norepinephrine transporter imaging agents..  32:593-605. 2005
  • Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography..  32:75-86. 2005
  • Synthesis and biological evaluation of [11C]talopram and [11C]talsupram: candidate PET ligands for the norepinephrine transporter..  31:705-718. 2004
  • Synthesis and evaluation of 2-amino-4-[(18)F]fluoro-2-methylbutanoic acid (FAMB): relationship of amino acid transport to tumor imaging properties of branched fluorinated amino acids..  30:477-490. 2003
  • Simultaneous evaluation of dual gene transfer to adherent cells by gamma-ray imaging.  28:135-144. 2001
  • Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients.  26:841-845. 1999
  • Effect of arteriovenous difference in measuring renal function by single-injection plasma clearance: Role of bolus.  26:699-705. 1999
  • Practical determination of organ S values for individual patients for therapy..  24:447-449. 1997
  • Practical determination of organ S values for individual patients for therapy.  24:447-449. 1997
  • Reproducibility of operator processing for radiation dosimetry.  24:77-83. 1997
  • A radioimmunoimaging and MIRD dosimetry treatment planning program for radioimmunotherapy.  23:525-532. 1996
  • A single-injection, two-sample method for measuring renal 99mTc-MAG3 clearance in both children and adults.  22:55-60. 1995
  • Estimation of ERPF in adults from plasma clearance of 131I-hippuran using a single injection and one or two blood samples.  16:381-383. 1989
  • International Standard Serial Number (issn)

  • 0883-2897
  • 0969-8051
  • Electronic International Standard Serial Number (eissn)

  • 1872-9614